These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37899386)

  • 21. Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy.
    Pober JS; Jane-wit D; Qin L; Tellides G
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1609-14. PubMed ID: 24903097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical dilemma of cardiac allograft vasculopathy--an introduction to the clinical session.
    von Scheidt W
    Z Kardiol; 2000; 89 Suppl 9():IX/40-4. PubMed ID: 11151791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients.
    Arora S; Andreassen AK; Karason K; Gustafsson F; Eiskjær H; Bøtker HE; Rådegran G; Gude E; Ioanes D; Solbu D; Dellgren G; Ueland T; Aukrust P; Gullestad L;
    Circ Heart Fail; 2018 Sep; 11(9):e004050. PubMed ID: 30354362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early optical coherence tomography evaluation of donor-transmitted atherosclerosis and cardiac allograft vasculopathy: insights from a prospective, single-center study.
    Takahashi T; Kobayashi Y; Saeed O; Vukelic S; Jorde UP; Shin JJ; Patel SR
    J Heart Lung Transplant; 2023 Dec; 42(12):1678-1687. PubMed ID: 37454771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression.
    Raichlin E; Bae JH; Kushwaha SS; Lennon RJ; Prasad A; Rihal CS; Lerman A
    J Am Coll Cardiol; 2009 Apr; 53(15):1279-86. PubMed ID: 19358941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease.
    Jonas M; Fang JC; Wang JC; Giri S; Elian D; Har-Zahav Y; Ly H; Seifert PA; Popma JJ; Rogers C
    J Am Coll Cardiol; 2006 Aug; 48(3):453-61. PubMed ID: 16875968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac allograft vasculopathy: a review.
    Weis M; von Scheidt W
    Circulation; 1997 Sep; 96(6):2069-77. PubMed ID: 9323100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravascular ultrasound for assessment of coronary allograft vasculopathy.
    König A; Theisen K; Klauss V
    Z Kardiol; 2000; 89 Suppl 9():IX/45-9. PubMed ID: 11151792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac allograft vasculopathy after heart transplantation: current prevention and treatment strategies.
    Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Iliopoulos DC; Voudris V; Siasos G
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):303-311. PubMed ID: 30657571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heat shock protein 27 is associated with freedom from graft vasculopathy after human cardiac transplantation.
    De Souza AI; Wait R; Mitchell AG; Banner NR; Dunn MJ; Rose ML
    Circ Res; 2005 Jul; 97(2):192-8. PubMed ID: 15976317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients.
    Nagumo S; Gallinoro E; Candreva A; Mizukami T; Monizzi G; Kodeboina M; Verstreken S; Dierckx R; Heggermont W; Bartunek J; Goethals M; Buytaert D; De Bruyne B; Sonck J; Collet C; Vanderheyden M
    J Interv Cardiol; 2020; 2020():9835151. PubMed ID: 32733172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The spectrum of coronary artery pathologic findings in human cardiac allografts.
    Johnson DE; Gao SZ; Schroeder JS; DeCampli WM; Billingham ME
    J Heart Transplant; 1989; 8(5):349-59. PubMed ID: 2795279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness.
    Imamura T; Kinugawa K; Murasawa T; Kagami Y; Endo M; Muraoka H; Fujino T; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Komuro I; Ono M
    Int Heart J; 2014; 55(2):178-80. PubMed ID: 24632967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-dimensional digital reconstruction of the murine coronary system for the evaluation of chronic allograft vasculopathy.
    Fónyad L; Shinoda K; Farkash EA; Groher M; Sebastian DP; Szász AM; Colvin RB; Yagi Y
    Diagn Pathol; 2015 Mar; 10():16. PubMed ID: 25884689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy.
    Daud A; Xu D; Revelo MP; Shah Z; Drakos SG; Dranow E; Stoddard G; Kfoury AG; Hammond MEH; Nativi-Nicolau J; Alharethi R; Miller DV; Gilbert EM; Wever-Pinzon O; McKellar SH; Afshar K; Khan F; Fang JC; Selzman CH; Stehlik J
    Circ Heart Fail; 2018 Aug; 11(8):e004759. PubMed ID: 30354559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational Analysis of Routine Biopsies Improves Diagnosis and Prediction of Cardiac Allograft Vasculopathy.
    Peyster EG; Janowczyk A; Swamidoss A; Kethireddy S; Feldman MD; Margulies KB
    Circulation; 2022 May; 145(21):1563-1577. PubMed ID: 35405081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microvascular coronary arterial vasculopathy--predictive value of endomyocardial biopsy.
    Lozano MD
    Z Kardiol; 2000; 89 Suppl 9():IX/54-7. PubMed ID: 11151794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor-Transmitted Atherosclerosis Associated With Worsening Cardiac Allograft Vasculopathy After Heart Transplantation: Serial Volumetric Intravascular Ultrasound Analysis.
    Watanabe T; Seguchi O; Yanase M; Fujita T; Murata Y; Sato T; Sunami H; Nakajima S; Kataoka Y; Nishimura K; Hisamatsu E; Kuroda K; Okada N; Hori Y; Wada K; Hata H; Ishibashi-Ueda H; Miyamoto Y; Fukushima N; Kobayashi J; Nakatani T
    Transplantation; 2017 Jun; 101(6):1310-1319. PubMed ID: 27472091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac allograft vasculopathy: current concepts.
    Ventura HO; Mehra MR; Smart FW; Stapleton DD
    Am Heart J; 1995 Apr; 129(4):791-9. PubMed ID: 7900633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.
    Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB
    J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.